Medical devices, healthcare technology and the business of care
510(k) clearance · K260945

Ultima System (UL-800);Ultimate Face Package (UL-800-Face-Set);Ultimate Shape Extension Kit 1 (UL-800-Shape-Ext-Kit-1);Ultimate Shape Extension Kit 2 (UL-800-Shape-Ext-Kit-2)

Fit-Pro KFT (Ltd.) - DBA E-Fit · Decision date Sep 27, 2026

MEDTECHLEDGER EXPLANATIONK260945

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 27, 2026 for K260945, a traditional 510(k) submitted March 23, 2026 by Fit-Pro KFT (Ltd.) - DBA E-Fit of Budapest, Hungary, with Medical Device Academy, Inc. as correspondent. The submission covers the Ultima System (UL-800) and three accessory packages: Ultimate Face Package (UL-800-Face-Set) and Ultimate Shape Extension Kits 1 and 2. The review panel was Physical Medicine, and the primary product code listed in the source record is NGX; the FDA letter also cites NFO and ILY.

The FDA letter describes two energy modalities, electrical stimulation and light output, operated separately and not delivered simultaneously. The NGX function is described for muscle conditioning of healthy muscles, and the NFO facial mode for aesthetic stimulation of labeled forehead and cheek sites on intact skin; the letter states neither is intended for rehabilitation or treatment of medical conditions. The letter lists K202148 and K242532 as predicates for the electrical stimulation comparison and K212275 and K15133 for the photostimulation comparison. SESE is a clearance, not a PMA approval. The source does not include the indications enclosure or performance data, so clinical support for the clearance is not established here.

The source does not state whether the accessory kits carry separate indications or limitations, and the listed product codes beyond NGX are not reconciled with the structured record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Physical Medicine
Decision date
Sep 27, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260945
Regulatory pathway
510(k) premarket notification
Product code
NGX
Decision code
SESE
Decision date
Sep 27, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, Muscle, Powered, For Muscle Conditioning.

Product code
NGX
FDA device class
2

FDA decision timeline

  1. K260945 received

    Application receipt date recorded by FDA.

  2. K260945 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NGX

Product / regulatory recordCompanyPathwayDecision dateSource
Changsha Anxiang Medical Technology Co., Ltd.510(k) clearanceOct 30, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Fit-Pro KFT (Ltd.) - DBA E-Fit

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Budapest

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records